Crinetics Pharmaceuticals, Inc.
CRNX
Classement en actions
#2228
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical... Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.
Prix de l'action
$84.95
Dernière synchronisation: 2026-09-01
Capitalisation boursière
$9.00B
Changement (1 jour)
0.00%
Changement (1 an)
98.25%
Pays
US
Échange Crinetics Pharmaceuticals, Inc. (CRNX)
Catégorie
Healthcare
Nombre d'actions en circulation pour Crinetics Pharmaceuticals, Inc. (CRNX)
Nombre d'actions en circulation au June 2026: 105.56M
Selon les derniers rapports financiers et le cours de l'action de Crinetics Pharmaceuticals, Inc., le nombre actuel d'actions en circulation est de 105.56M. À la fin de December 2023, l'entreprise avait 58.07M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Crinetics Pharmaceuticals, Inc. (CRNX) de 2016 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 105.56M | 30.67% |
| 2024 | 80.78M | 39.11% |
| 2023 | 58.07M | 11.71% |
| 2022 | 51.98M | 35.24% |
| 2021 | 38.44M | 26.23% |
| 2020 | 30.45M | 25.95% |
| 2019 | 24.18M | 99.10% |
| 2018 | 12.14M | -12.51% |
| 2017 | 13.88M | 0.00% |
| 2016 | 13.88M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 140.53% |
US
|
|
| 396.00M | 275.14% |
US
|
|
| 478.91M | 353.69% |
AU
|
|
| 62.19M | -41.09% |
NL
|
|
| - | - |
CH
|
